BC Craft Supply Co. Ltd. (CRFTF)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
BC Craft Supply Co. Ltd. (CRFTF) trades at $0.00. BC Craft Supply Co. Ltd. is a Canadian life sciences firm focused on cannabinoid and psychedelic research for therapeutic applications. Market cap: $23, Sector: Healthcare.
Price live · AI analysis from Jun 14, 2026Analyst Coverage for CRFTF: CRFTF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates CRFTF against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
CRFTF: 1/1 perspectives are bearish.
How is this calculated? →BC Craft Supply Co. Ltd. (CRFTF) Healthcare & Pipeline Overview
BC Craft Supply Co. Ltd. operates as a multifaceted life sciences enterprise, pioneering advancements in cannabinoid and psychedelic research for therapeutic applications. The company strategically consolidates artisan cannabis, manages cultivation facilities, and develops pre-clinical neuroplasticity solutions, positioning itself across both the Canadian and Californian emerging markets.
What Is the Investment Thesis for CRFTF?
BC Craft Supply Co. Ltd. is positioned within the evolving cannabinoid and psychedelic research sectors, aiming to capitalize on the growing demand for both craft cannabis and novel therapeutic applications. The company's strategy involves consolidating artisan cannabis through CRFT, operating cultivation facilities via Medcann Health Products, and expanding into the California market with Feelwell Brands. A key value driver is its pre-clinical biotechnology arm, AVA Pathways, which focuses on neuroplasticity and psychedelic compounds, potentially unlocking significant long-term growth in mental health solutions. However, the company faces substantial challenges, evidenced by a profit margin of -2613.0% and a gross margin of 5.8%, indicating significant operational inefficiencies or early-stage investment. Its high Beta of 5.15 suggests considerable price volatility. As an OTC Other listed stock, CRFTF carries inherent risks related to lower liquidity and less stringent disclosure requirements. Future performance hinges on effective scaling of operations, successful navigation of complex regulatory landscapes in both cannabis and psychedelics, and maintaining access to capital to fund ongoing research and market expansion.
Based on FMP financials and quantitative analysis
CRFTF Key Highlights
- The company maintains a gross margin of 5.8%, indicating the percentage of revenue remaining after accounting for the cost of goods sold.
- BC Craft Supply Co. Ltd. reported a profit margin of -2613.0%, reflecting significant losses relative to its revenue.
- With a market capitalization of 23, the company currently holds a minimal valuation in the public markets.
- The stock exhibits a high Beta of 5.15, suggesting it is significantly more volatile than the broader market.
- BC Craft Supply Co. Ltd. does not currently pay a dividend, as indicated by a dividend yield of None.
Who Are CRFTF's Competitors?
CRFTF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| ALVO Alvotech | $3.51 | -2.77% | $1.19B | 69 |
| AERI Aerie Pharmaceuticals, Inc. | $15.25 | +0.00% | 68 | |
| KIN Kindred Biosciences, Inc. | $9.25 | +0.11% | 68 | |
| CNVCF BioHarvest Sciences Inc. | $6.30 | +0.00% | $109.16M | 66 |
| ALIM Alimera Sciences, Inc. | $5.54 | -0.18% | $301.29M | 60 |
| EGRX Eagle Pharmaceuticals, Inc. | $0.67 | +0.00% | $8.82M | 60 |
| ADMP Adamis Pharmaceuticals Corporation | $0.78 | +0.85% | $7.25M | 61 |
| DCPH Deciphera Pharmaceuticals | $25.59 | +0.08% | $2.21B | 61 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are CRFTF's Key Strengths?
- Diversified portfolio across craft cannabis, cultivation, cannabinoid brands, and psychedelic research.
- Strategic presence in both Canadian and Californian cannabis markets.
- Focus on the growing craft cannabis segment and emerging psychedelic therapeutics.
- Established cultivation and processing facility via Medcann Health Products.
- Pioneering pre-clinical research in neuroplasticity with AVA Pathways.
What Are CRFTF's Weaknesses?
- Significant negative profit margin (-2613.0%) indicating substantial losses.
- Low gross margin (5.8%) suggesting high cost of goods or pricing pressures.
- Operates as an OTC Other listed stock, implying lower liquidity and less transparency.
- High Beta (5.15) indicates extreme price volatility and market risk.
- Pre-clinical nature of AVA Pathways means long timelines and high risk for drug development.
What Could Drive CRFTF Stock Higher?
- Potential regulatory advancements in Canada or California that could expand market access or product categories for cannabis.
- Positive pre-clinical data or progression of AVA Pathways' psychedelic compounds into clinical trials, signaling therapeutic potential.
- Expansion of CRFT's network of artisan cannabis cultivators and increased market penetration in the Canadian craft segment.
- Development and launch of new cannabinoid products under Feelwell Brands in the California market.
- Strategic partnerships or collaborations that could enhance distribution, research capabilities, or market reach.
What Are the Key Risks for CRFTF?
- Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
- Significant financial losses and negative profit margins may lead to ongoing cash burn and require further capital raises.
- High stock volatility (Beta 5.15) could result in substantial and rapid share price fluctuations.
- Regulatory changes or increased scrutiny in the cannabis and psychedelic sectors could impact operations and market opportunities.
- Intense competition from larger, better-funded companies in both the cannabis and pharmaceutical industries.
- Risks associated with an OTC Other listing, including low liquidity, limited transparency, and potential for market manipulation.
What Are the Growth Opportunities for CRFTF?
- **Expansion in the Canadian Craft Cannabis Market:** CRFT's role as a curator and consolidator of artisan cannabis positions BC Craft Supply Co. Ltd. to capitalize on the increasing consumer demand for premium, small-batch products in Canada. As the legal cannabis market matures, discerning consumers are often willing to pay a premium for quality and unique strains, a segment that CRFT is designed to serve. This niche market, while smaller than the mass market, often boasts higher margins and strong brand loyalty. Continued expansion of CRFT's network of small-batch cultivators and enhanced distribution channels could significantly grow this segment's revenue, leveraging the company's expertise in navigating regulatory frameworks for craft producers.
- **Growth in the California Cannabinoid Market:** Feelwell Brands, with its license in California, offers a substantial growth opportunity by tapping into one of the largest and most influential cannabis markets globally. California's market size and its trend-setting influence provide a fertile ground for cannabinoid brand development and expansion. By strategically developing and marketing a diverse portfolio of cannabinoid products under the Feelwell umbrella, BC Craft Supply Co. Ltd. can capture a significant share of this high-value market. Success in California could also serve as a blueprint for expansion into other legalized U.S. states, leveraging brand recognition and operational experience gained in this competitive environment.
- **Advancements in Psychedelic Research via AVA Pathways:** The pre-clinical biotechnology firm, AVA Pathways, represents a significant long-term growth opportunity by focusing on neuroplasticity and mental health solutions through psilocybin and other mushroom-derived compounds. The global market for psychedelic therapeutics is projected to grow substantially as research progresses and regulatory bodies consider their medical applications. Early-stage research and development in this field, while high-risk, offers the potential for groundbreaking discoveries and lucrative patent opportunities. Successful progression of AVA Pathways' compounds through clinical trials could position BC Craft Supply Co. Ltd. as a key player in the emerging psychedelic medicine industry, addressing a vast unmet need in mental health.
- **Diversification of Cannabis Product Offerings:** Medcann Health Products, with its cultivation and processing facility in Chemainus, provides the infrastructure to diversify BC Craft Supply Co. Ltd.'s cannabis product offerings beyond traditional flower. This includes developing and producing a range of value-added products such as edibles, concentrates, vapes, and topicals for both medical and recreational markets across Canada. The market for these derivative products is growing faster than that for dried flower, driven by consumer preference for convenience, discretion, and varied consumption methods. Expanding the product portfolio can capture new consumer segments, increase market share, and enhance revenue streams by catering to evolving consumer tastes and preferences.
- **Strategic Partnerships and Acquisitions:** Given the fragmented nature of both the craft cannabis and nascent psychedelic industries, strategic partnerships and targeted acquisitions represent a significant growth avenue. Collaborating with other research institutions, technology providers, or established distribution networks can accelerate market penetration and product development. Acquiring smaller, innovative companies with complementary technologies, intellectual property, or market access could rapidly expand BC Craft Supply Co. Ltd.'s portfolio and competitive advantages. Such inorganic growth strategies could provide access to new markets, enhance research capabilities, and consolidate market share more quickly than organic growth alone, especially in capital-intensive sectors like biotechnology and regulated cannabis.
What Opportunities Does CRFTF Have?
- Expansion within the growing legal cannabis markets in Canada and California.
- Potential for groundbreaking discoveries and commercialization in psychedelic therapeutics.
- Increasing consumer demand for premium, artisan cannabis products.
- Strategic partnerships or acquisitions to expand market reach and research capabilities.
- Diversification into value-added cannabis products beyond dried flower.
What Threats Does CRFTF Face?
- Intense competition from larger, well-funded cannabis companies and pharmaceutical firms.
- Evolving and complex regulatory landscapes in both cannabis and psychedelics.
- Challenges in scaling operations effectively and maintaining access to capital.
- Risk of research failures or lengthy approval processes for psychedelic compounds.
- Market volatility and liquidity issues associated with OTC Other listing.
What Are CRFTF's Competitive Advantages?
- Strategic positioning in the craft cannabis segment, catering to a niche market with potentially higher margins and brand loyalty.
- Diversified portfolio spanning both cannabinoid products and pre-clinical psychedelic research, mitigating reliance on a single market.
- Established cultivation and processing infrastructure in Canada through Medcann Health Products, ensuring supply chain control.
- Early-mover advantage in pre-clinical psychedelic research via AVA Pathways, exploring novel mental health treatments.
- Licensing and operational presence in the significant California cannabis market through Feelwell Brands.
What Does CRFTF Do?
BC Craft Supply Co. Ltd. is a multifaceted life sciences enterprise headquartered in Vancouver, Canada, dedicated to pioneering advancements in cannabinoid and psychedelic research, specifically targeting innovative therapeutic and psychotherapeutic applications. The company, which was formerly known as Pasha Brands Ltd. before adopting its current name in May 2020, has strategically diversified its operations across several key ventures within these burgeoning sectors. At its core, CRFT functions as a discerning curator and consolidator of artisan cannabis, playing a crucial role in championing small-batch cultivators and facilitating their access and entry into the competitive Canadian market. This segment focuses on quality and authenticity, aiming to meet the demand for premium cannabis products. Further expanding its footprint in the cannabis industry, Medcann Health Products operates a cultivation and processing facility located in Chemainus. This facility is pivotal in serving both the medical and recreational cannabis sectors across Canada, ensuring a consistent supply chain and product development capabilities. In a strategic move to penetrate the significant U.S. market, Feelwell Brands operates as a cannabinoid brand collective, holding a license specifically in California, a key state for cannabis innovation and consumption. This allows BC Craft Supply Co. Ltd. to tap into a broader consumer base and explore diverse product lines. Beyond cannabinoids, the company is actively engaged in the frontier of psychedelic research through AVA Pathways. This pre-clinical biotechnology firm is intensely focused on neuroplasticity, exploring mental health solutions through the study of psilocybin and other mushroom-derived compounds. This venture represents a forward-looking commitment to developing novel treatments for mental health conditions, leveraging the therapeutic potential of psychedelics. Through this diverse portfolio, BC Craft Supply Co. Ltd. aims to establish a significant presence across the life sciences landscape, from craft cannabis market consolidation to cutting-edge psychedelic drug discovery.
What Products and Services Does CRFTF Offer?
- Curates and consolidates artisan cannabis from small-batch cultivators for the Canadian market through its CRFT venture.
- Operates a cultivation and processing facility via Medcann Health Products for medical and recreational cannabis in Canada.
- Manages Feelwell Brands, a cannabinoid brand collective with a license to operate in California, USA.
- Conducts pre-clinical biotechnology research on neuroplasticity using psilocybin and other mushroom-derived compounds through AVA Pathways.
- Focuses on developing innovative therapeutic and psychotherapeutic applications for cannabinoids and psychedelics.
- Facilitates market entry for small-batch cannabis cultivators in Canada, supporting the craft segment.
- Explores mental health solutions through its psychedelic research arm.
How Does CRFTF Make Money?
- Revenue generation from the sale of curated craft cannabis products in Canada.
- Sales of medical and recreational cannabis products cultivated and processed at the Medcann Health Products facility.
- Brand development and sales of cannabinoid products in the California market through Feelwell Brands.
- Potential future revenue from intellectual property, licensing, or commercialization of psychedelic compounds developed by AVA Pathways.
- Providing infrastructure and services to craft cannabis cultivators.
What Industry Does CRFTF Operate In?
BC Craft Supply Co. Ltd. operates within the dynamic and rapidly evolving healthcare sector, specifically targeting the Drug Manufacturers - Specialty & Generic industry with a unique focus on cannabinoids and psychedelics. The global cannabis market is experiencing significant growth, driven by increasing legalization for medical and recreational use, with projections indicating continued expansion. Similarly, the psychedelic therapeutics market is an emerging frontier, attracting substantial research and investment due to the potential of compounds like psilocybin for mental health treatments. BC Craft Supply Co. Ltd. positions itself by addressing both these trends: through CRFT, it taps into the premium craft cannabis segment, differentiating from larger, mass-market producers. Its Medcann and Feelwell brands aim for broader market penetration in Canada and California, respectively. AVA Pathways places it in the nascent but high-potential psychedelic research space, competing with a growing number of biotech firms exploring neuroplasticity. The competitive landscape includes established pharmaceutical companies, large-scale cannabis cultivators, and specialized biotech startups, all vying for market share in these innovative but highly regulated fields.
Who Are CRFTF's Key Customers?
- Canadian consumers of legal medical and recreational cannabis, particularly those seeking premium, artisan products.
- Consumers in California seeking cannabinoid products under the Feelwell Brands collective.
- Medical patients in Canada requiring cannabis for therapeutic purposes.
- Small-batch cannabis cultivators seeking market access and consolidation services in Canada.
- Potentially, pharmaceutical companies or healthcare providers for future psychedelic therapeutics developed by AVA Pathways.
ROE 25%Key Financial Metrics
Return on equity for BC Craft Supply Co. Ltd. stands at 24.9%, a gauge of how efficiently it converts shareholder capital into profit. A current ratio of 0.02 means current liabilities exceed short-term assets, a liquidity point worth watching.
BC Craft Supply Co. Ltd. (CRFTF) Valuation Context
Valued at 23, CRFTF is classified as a micro-cap stock.
Company Profile
BC Craft Supply Co. Ltd. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Vancouver, CA. The company is led by CEO Bradley Macauley. CRFTF has traded publicly since 2019.
F-Score 3/9Financial Health
BC Craft Supply Co. Ltd.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.
CRFTF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests those in the know see value, signaling potential upside.
- The community buzz is generally positive, indicating strong belief in the company's vision and execution.
- Market perception seems to be improving, with more articles and discussions highlighting the company's potential.
- The company's focus on craft cannabis resonates with a growing segment of consumers seeking premium products.
Bear Case
- Insider activity, while showing some buying, could be interpreted as a move to boost confidence amid concerns.
- Despite overall positive community sentiment, there are pockets of worry about increasing competition in the craft cannabis space.
- Market perception is still volatile, with the company susceptible to broader market downturns affecting cannabis stocks.
- The craft cannabis market, while growing, is still niche, and scaling up to meet demand could present challenges.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
CRFTF Latest News
No recent news available for CRFTF.
CRFTF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for CRFTF.
Price Targets
Wall Street price target analysis for CRFTF.
CRFTF MoonshotScore
What does this score mean?
The MoonshotScore rates CRFTF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Bradley Macauley
CEO
Unknown
Track Record: Unknown
CRFTF OTC Market Information
BC Craft Supply Co. Ltd. trades on the OTC Other tier, which is the lowest and least regulated tier of the OTC Markets Group. Unlike stocks listed on major exchanges like NYSE or NASDAQ, or even higher OTC tiers like OTCQB or OTCQX, companies on the OTC Other tier are not required to meet minimum financial standards or file regular reports with the SEC. This tier typically includes companies that are very small, distressed, or do not meet the requirements for higher tiers, offering significantly less transparency and investor protection compared to other public markets. Investors should be aware of the inherent risks associated with this classification.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited public information and less stringent disclosure requirements compared to major exchanges.
- Lower trading volume and wider bid-ask spreads, leading to reduced liquidity and difficulty in executing trades.
- Increased susceptibility to price manipulation due to less oversight and smaller market capitalization.
- Limited analyst coverage and institutional interest, which can hinder accurate valuation and market efficiency.
- Potential for delisting or further regulatory actions if disclosure status remains unknown or inadequate.
- Verify the company's current operational status and revenue streams beyond public filings.
- Scrutinize available financial statements, even if unaudited, for consistency and red flags.
- Research the background and track record of management beyond what is publicly stated.
- Understand the company's share structure, including any convertible notes or warrants that could dilute existing shareholders.
- Assess the regulatory environment specific to its cannabis and psychedelic operations in Canada and California.
- Investigate any pending litigation or regulatory actions against the company or its subsidiaries.
- Evaluate the company's access to capital and its ability to fund ongoing operations and growth initiatives.
- Clearly defined business segments including CRFT, Medcann Health Products, Feelwell Brands, and AVA Pathways.
- Specific operational locations mentioned, such as Chemainus for Medcann and Vancouver for HQ.
- Named CEO, Bradley Macauley, indicating identifiable leadership.
- Engagement in regulated industries (cannabis) and emerging research (psychedelics) with specific licenses (California).
- History of name change from Pasha Brands Ltd. to BC Craft Supply Co. Ltd. in May 2020, indicating corporate evolution.
BC Craft Supply Co. Ltd. Healthcare Stock: Key Questions Answered
What does BC Craft Supply Co. Ltd. do?
BC Craft Supply Co. Ltd. operates as a diversified life sciences company with a strategic focus on both the cannabinoid and psychedelic sectors. Its operations are segmented into several key areas: CRFT curates and consolidates artisan cannabis from small-batch cultivators, facilitating their entry into the Canadian market. Medcann Health Products manages a cultivation and processing facility in Chemainus, serving both medical and recreational cannabis users across Canada. Feelwell Brands is a cannabinoid brand collective with a license to operate in California, aiming to capture market share in this significant U.S. state. Additionally, the company is engaged in cutting-edge research through AVA Pathways, a pre-clinical biotechnology firm dedicated to exploring neuroplasticity and developing mental health solutions using psilocybin and other mushroom-derived compounds. This multi-faceted approach positions the company across various segments of the evolving cannabis and psychedelic industries.
What are the main risks for CRFTF?
Investing in CRFTF carries several significant risks. Financially, the company exhibits substantial losses, as evidenced by a profit margin of -2613.0%, and a low gross margin of 5.8%, indicating potential operational inefficiencies or high cost structures. Its listing on the OTC Other tier exposes investors to risks such as lower liquidity, less stringent disclosure requirements, and increased susceptibility to price volatility, highlighted by a high Beta of 5.15. Operationally, the company faces intense competition in both the established cannabis market and the nascent psychedelic research space. Regulatory risks are also prominent, with evolving and complex legal frameworks governing cannabis in Canada and California, and the uncertain path for psychedelic therapeutics. Furthermore, the pre-clinical nature of AVA Pathways means that drug development is a long, costly, and high-risk endeavor with no guarantee of success or commercialization.
How does BC Craft Supply Co. Ltd. position itself in the evolving cannabinoid and psychedelic research landscape?
BC Craft Supply Co. Ltd. strategically positions itself within the evolving cannabinoid and psychedelic research landscape through a diversified and targeted approach. In the cannabinoid sector, it leverages CRFT to tap into the premium, high-margin craft cannabis segment in Canada, differentiating itself from larger producers by focusing on quality and supporting small-batch cultivators. Concurrently, Medcann Health Products provides a foundational cultivation and processing capability for broader Canadian medical and recreational markets, ensuring supply chain control. Its Feelwell Brands venture in California allows direct engagement with one of the most dynamic and influential cannabinoid markets globally. In the psychedelic research space, AVA Pathways represents a forward-looking investment into neuroplasticity and mental health solutions using compounds like psilocybin. This dual focus allows the company to capitalize on the immediate growth in regulated cannabis markets while also pursuing the significant long-term therapeutic potential of psychedelics, aiming to establish a foothold in two distinct but related emerging healthcare frontiers.
What are the key factors to evaluate for CRFTF?
Evaluate CRFTF on fundamentals, analyst consensus, and risk factors. Not financial advice.
How frequently does CRFTF data refresh on this page?
CRFTF prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven CRFTF's recent stock price performance?
BC Craft Supply Co. Ltd. (CRFTF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diversified portfolio across craft cannabis, cultivation, cannabinoid brands, and psychedelic research. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider CRFTF overvalued or undervalued right now?
Valuing BC Craft Supply Co. Ltd. (CRFTF) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying CRFTF?
Before investing in BC Craft Supply Co. Ltd. (CRFTF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- CEO background and track record are marked as 'Unknown' as no specific details were provided in the source data beyond the name.
- Competitors section is empty because no FMP PEER TICKERS were provided in the source data.
- OTC Disclosure Status is 'Unknown' as per source data.
- TenureYears for CEO is null as no start date was provided.